Is Broadcom Stock Overvalued?
The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…
Sell
29
MRUS Quote, Financials, Valuation and Earnings
Last price:
$43.85
Seasonality move
:
0.36%
Day range:
$41.38 - $47.75
52-week range:
$31.27 - $61.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
75.06x
P/B ratio:
4.27x
Volume:
1.8M
Avg. volume:
614.6K
1-year change:
33.36%
Market cap:
$3B
Revenue:
$43.9M
EPS (TTM):
-$3.95
Analysts' Opinion
-
Consensus RatingMerus NV has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $86.07, Merus NV has an estimated upside of 96.29% from its current price of $43.85.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $67.00 representing 100% downside risk from its current price of $43.85.
Fair Value
-
According to the consensus of 12 analysts, Merus NV has 96.29% upside to fair value with a price target of $86.07 per share.
MRUS vs. S&P 500
-
Over the past 5 trading days, Merus NV has overperformed the S&P 500 by 5.72% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Merus NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Merus NV has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Merus NV reported revenues of $11.8M.
Earnings Growth
-
Merus NV has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Merus NV reported earnings per share of -$1.46.
Enterprise value:
2.4B
EV / Invested capital:
--
Price / LTM sales:
75.06x
EV / EBIT:
--
EV / Revenue:
65.95x
PEG ratio (5yr expected):
-2.20x
EV / Free cash flow:
-15.07x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-38.42%
Net Income Margin (TTM):
-680.61%
Return On Equity:
-47.97%
Return On Invested Capital:
-47.97%
Operating Margin:
-613.59%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $45.6M | $45.7M | $35.9M | $11M | $11.8M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$129.2M | -$162.7M | -$231M | -$38.4M | -$72.2M | |
| EBITDA | -$127.9M | -$160.4M | -$228.5M | -$37.7M | -$71.6M | |
| Diluted EPS | -$1.43 | -$3.76 | -$3.95 | -$0.43 | -$1.46 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $201.3M | $319.7M | $368.2M | $404.8M | $666.3M | |
| Total Assets | $213.5M | $355.9M | $415M | $492.2M | $844.7M | |
| Current Liabilities | $45.4M | $71.5M | $64.2M | $64.3M | $80.1M | |
| Total Liabilities | $129M | $150.2M | $116.2M | $98.8M | $141.4M | |
| Total Equity | $84.5M | $205.8M | $298.8M | $393.4M | $703.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$151M | -$136.4M | -$155.5M | -$27.5M | -$80.4M | |
| Cash From Investing | -$13.8M | -$24M | -$144.6M | $8M | -$133.7M | |
| Cash From Financing | $186M | $228.4M | $487.4M | $162.4M | $10.9M | |
| Free Cash Flow | -$156.8M | -$142.5M | -$157.3M | -$27.6M | -$80.7M | |
MRUS
Sector
Market Cap
$3B
$47.5M
Price % of 52-Week High
71.17%
47.37%
Dividend Yield
0%
0%
Shareholder Yield
-13.38%
-0.74%
1-Year Price Total Return
33.36%
-34.04%
Beta (5-Year)
1.104
0.752
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$42.65
200-day SMA
Sell
Level
$49.25
Bollinger Bands (100)
Sell
Level
44.44 - 52.5
Chaikin Money Flow
Buy
Level
16.6M
20-day SMA
Buy
Level
$42.65
Relative Strength Index (RSI14)
Buy
Level
51.03
ADX Line
Buy
Level
19.58
Williams %R
Neutral
Level
-59.816
50-day SMA
Sell
Level
$45.80
MACD (12, 26)
Sell
Level
-0.70
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
35.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.0603)
Sell
CA Score
(Annual)
Level (-1.0867)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.9206)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
Stock Forecast FAQ
In the current month, MRUS has received 12 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MRUS average analyst price target in the past 3 months is $86.07.
-
Where Will Merus NV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Merus NV share price will rise to $86.07 per share over the next 12 months.
-
What Do Analysts Say About Merus NV?
Analysts are divided on their view about Merus NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Merus NV is a Sell and believe this share price will drop from its current level to $67.00.
-
What Is Merus NV's Price Target?
The price target for Merus NV over the next 1-year time period is forecast to be $86.07 according to 12 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MRUS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Merus NV is a Buy. 12 of 12 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MRUS?
You can purchase shares of Merus NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Merus NV shares.
-
What Is The Merus NV Share Price Today?
Merus NV was last trading at $43.85 per share. This represents the most recent stock quote for Merus NV. Yesterday, Merus NV closed at $43.85 per share.
-
How To Buy Merus NV Stock Online?
In order to purchase Merus NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
4 Top Dividend Stocks to Buy Now
If you’re looking for steady income, dividend stocks are a…
Will Uber Stock Recover?
Shares of Uber Technologies (NYSE:UBER) have had a rough few…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 39x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 114x
Sell
39
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
87
CEG alert for Jan 11
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
1
MCY alert for Jan 11
Mercury General [MCY] is down 19.87% over the past day.
Buy
84
ATZAF alert for Jan 11
Aritzia [ATZAF] is up 17.63% over the past day.
